US Stock MarketDetailed Quotes

TEVA Teva Pharmaceutical Industries

Watchlist
  • 22.210
  • +0.120+0.54%
Close Dec 23 16:00 ET
  • 22.210
  • 0.0000.00%
Post 16:05 ET
25.17BMarket Cap-26.13P/E (TTM)

Teva Pharmaceutical Industries Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
12.49%4.33B
7.40%4.16B
4.29%3.82B
6.16%15.85B
14.78%4.46B
7.09%3.85B
2.43%3.88B
0.03%3.66B
-6.01%14.93B
-5.29%3.88B
Operating revenue
13.29%4.23B
7.61%4.06B
3.67%3.7B
5.37%15.28B
9.85%4.21B
8.02%3.73B
2.50%3.77B
0.99%3.57B
-5.74%14.5B
-3.99%3.83B
Cost of revenue
9.20%2.18B
2.79%2.14B
-1.49%2.05B
3.12%8.2B
-3.41%2.04B
3.79%2B
4.52%2.08B
8.22%2.08B
-4.01%7.95B
3.07%2.11B
Gross profit
16.05%2.15B
12.69%2.02B
11.95%1.77B
9.64%7.65B
36.44%2.42B
10.90%1.85B
0.11%1.8B
-9.08%1.58B
-8.18%6.97B
-13.66%1.77B
Operating expense
6.11%1.16B
5.04%1.21B
5.12%1.13B
3.92%4.45B
-0.53%1.13B
10.25%1.1B
4.45%1.15B
1.99%1.07B
-4.72%4.28B
-7.35%1.14B
Selling and administrative expenses
9.48%924M
3.19%939M
5.23%886M
1.54%3.5B
7.77%902M
2.68%844M
0.33%910M
-4.32%842M
-2.35%3.45B
-7.82%837M
-Selling and marketing expense
8.68%626M
8.79%656M
11.36%608M
3.13%2.34B
11.11%610M
6.86%576M
1.52%603M
-6.51%546M
-6.75%2.27B
-13.00%549M
-General and administrative expense
11.19%298M
-7.82%283M
-6.08%278M
-1.53%1.16B
1.39%292M
-5.30%268M
-1.92%307M
0.00%296M
7.37%1.18B
3.97%288M
Research and development costs
-5.14%240M
12.08%269M
3.42%242M
13.72%953M
8.10%227M
44.57%253M
5.26%240M
4.00%234M
-13.34%838M
-13.93%210M
Other operating expenses
----
----
150.00%1M
----
----
----
----
96.15%-2M
----
----
Operating profit
30.50%984M
26.32%816M
26.38%642M
18.74%3.19B
102.52%1.29B
11.87%754M
-6.78%646M
-26.06%508M
-13.20%2.69B
-23.03%635M
Net non-operating interest income expense
2.86%-272M
10.07%-241M
3.85%-250M
-10.49%-1.1B
-6.30%-287M
-11.11%-280M
-27.01%-268M
-0.78%-260M
-3.01%-991M
-71.97%-270M
Non-operating interest expense
-2.86%272M
-10.07%241M
-3.85%250M
10.65%1.03B
5.74%221M
11.11%280M
27.01%268M
0.78%260M
4.38%930M
143.02%209M
Total other finance cost
----
----
----
8.20%66M
----
----
----
----
-14.08%61M
----
Other net income (expense)
-152.57%-1.03B
36.77%-822M
-64.88%-859M
43.96%-2.72B
68.42%-493M
-60.39%-409M
20.88%-1.3B
62.79%-521M
-228.31%-4.86B
-84.73%-1.56B
Gain on sale of security
----
----
----
46.15%38M
----
----
----
----
126.80%26M
----
Special income (charges)
-153.13%-1.05B
37.84%-823M
-71.29%-877M
43.47%-2.75B
68.91%-495M
-63.78%-416M
19.02%-1.32B
62.87%-512M
-256.23%-4.86B
-109.20%-1.59B
-Less：Restructuring and merger&acquisition
1.85%55M
138.64%210M
1.10%92M
61.92%659M
124.21%426M
74.19%54M
-8.33%88M
1.11%91M
190.71%407M
272.55%190M
-Less:Impairment of capital assets
1,041.67%548M
-31.52%530M
261.17%679M
-55.95%1.08B
-95.29%68M
71.43%48M
-4.44%774M
13.94%188M
319.01%2.45B
689.62%1.45B
-Less:Other special charges
43.31%450M
-82.03%83M
-54.51%106M
-49.83%1.04B
38.10%29M
61.03%314M
-36.63%462M
-79.27%233M
196.42%2.07B
-96.41%21M
-Gain on sale of business
----
----
----
-93.48%3M
----
----
----
----
-9.80%46M
----
-Gain on sale of property,plant,equipment
----
----
----
38.89%25M
----
----
----
----
157.14%18M
----
Other non- operating income (expenses)
185.71%20M
-95.83%1M
300.00%18M
46.15%-14M
-820.00%-36M
800.00%7M
400.00%24M
57.14%-9M
-36.84%-26M
-61.54%5M
Income before tax
-606.25%-324M
73.35%-246M
-71.69%-467M
80.27%-624M
142.29%507M
-61.45%64M
20.43%-923M
71.99%-272M
-580.70%-3.16B
-585.14%-1.2B
Income tax
675.00%69M
4,037.50%630M
-173.68%-52M
98.91%-7M
-72.48%41M
-111.21%-12M
98.22%-16M
-1,050.00%-19M
-404.74%-643M
720.83%149M
Earnings from equity interest net of tax
--3M
100.00%2M
---4M
-90.48%2M
0.00%1M
----
--1M
----
133.33%21M
--1M
Net income
-606.49%-390M
3.53%-874M
-65.61%-419M
75.39%-615M
134.67%467M
32.76%77M
-249.81%-906M
73.42%-253M
-648.03%-2.5B
-786.18%-1.35B
Net income continuous Operations
-613.16%-390M
3.53%-874M
-65.61%-419M
75.39%-615M
134.67%467M
31.03%76M
-248.46%-906M
73.42%-253M
-648.03%-2.5B
-792.05%-1.35B
Minority interest income
487.50%47M
17.14%-29M
-748.48%-280M
-5.66%-56M
112.50%4M
166.67%8M
-29.63%-35M
-1,200.00%-33M
-235.90%-53M
-557.14%-32M
Net income attributable to the parent company
-733.33%-437M
2.98%-846M
36.82%-139M
77.15%-559M
135.24%463M
23.21%69M
-275.86%-872M
76.96%-220M
-686.57%-2.45B
-726.42%-1.31B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-733.33%-437M
2.98%-846M
36.82%-139M
77.15%-559M
135.24%463M
23.21%69M
-275.86%-872M
76.96%-220M
-686.57%-2.45B
-726.42%-1.31B
Basic earnings per share
-750.00%-0.39
3.85%-0.75
40.00%-0.12
77.27%-0.5
137.27%0.41
20.00%0.06
-271.43%-0.78
76.74%-0.2
-678.95%-2.2
-685.71%-1.1
Diluted earnings per share
-750.00%-0.39
3.85%-0.75
40.00%-0.12
77.27%-0.5
137.27%0.41
20.00%0.06
-271.43%-0.78
76.74%-0.2
-678.95%-2.2
-685.71%-1.1
Dividend per share
0
0
0
0
0
0
0
0
0
0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 12.49%4.33B7.40%4.16B4.29%3.82B6.16%15.85B14.78%4.46B7.09%3.85B2.43%3.88B0.03%3.66B-6.01%14.93B-5.29%3.88B
Operating revenue 13.29%4.23B7.61%4.06B3.67%3.7B5.37%15.28B9.85%4.21B8.02%3.73B2.50%3.77B0.99%3.57B-5.74%14.5B-3.99%3.83B
Cost of revenue 9.20%2.18B2.79%2.14B-1.49%2.05B3.12%8.2B-3.41%2.04B3.79%2B4.52%2.08B8.22%2.08B-4.01%7.95B3.07%2.11B
Gross profit 16.05%2.15B12.69%2.02B11.95%1.77B9.64%7.65B36.44%2.42B10.90%1.85B0.11%1.8B-9.08%1.58B-8.18%6.97B-13.66%1.77B
Operating expense 6.11%1.16B5.04%1.21B5.12%1.13B3.92%4.45B-0.53%1.13B10.25%1.1B4.45%1.15B1.99%1.07B-4.72%4.28B-7.35%1.14B
Selling and administrative expenses 9.48%924M3.19%939M5.23%886M1.54%3.5B7.77%902M2.68%844M0.33%910M-4.32%842M-2.35%3.45B-7.82%837M
-Selling and marketing expense 8.68%626M8.79%656M11.36%608M3.13%2.34B11.11%610M6.86%576M1.52%603M-6.51%546M-6.75%2.27B-13.00%549M
-General and administrative expense 11.19%298M-7.82%283M-6.08%278M-1.53%1.16B1.39%292M-5.30%268M-1.92%307M0.00%296M7.37%1.18B3.97%288M
Research and development costs -5.14%240M12.08%269M3.42%242M13.72%953M8.10%227M44.57%253M5.26%240M4.00%234M-13.34%838M-13.93%210M
Other operating expenses --------150.00%1M----------------96.15%-2M--------
Operating profit 30.50%984M26.32%816M26.38%642M18.74%3.19B102.52%1.29B11.87%754M-6.78%646M-26.06%508M-13.20%2.69B-23.03%635M
Net non-operating interest income expense 2.86%-272M10.07%-241M3.85%-250M-10.49%-1.1B-6.30%-287M-11.11%-280M-27.01%-268M-0.78%-260M-3.01%-991M-71.97%-270M
Non-operating interest expense -2.86%272M-10.07%241M-3.85%250M10.65%1.03B5.74%221M11.11%280M27.01%268M0.78%260M4.38%930M143.02%209M
Total other finance cost ------------8.20%66M-----------------14.08%61M----
Other net income (expense) -152.57%-1.03B36.77%-822M-64.88%-859M43.96%-2.72B68.42%-493M-60.39%-409M20.88%-1.3B62.79%-521M-228.31%-4.86B-84.73%-1.56B
Gain on sale of security ------------46.15%38M----------------126.80%26M----
Special income (charges) -153.13%-1.05B37.84%-823M-71.29%-877M43.47%-2.75B68.91%-495M-63.78%-416M19.02%-1.32B62.87%-512M-256.23%-4.86B-109.20%-1.59B
-Less：Restructuring and merger&acquisition 1.85%55M138.64%210M1.10%92M61.92%659M124.21%426M74.19%54M-8.33%88M1.11%91M190.71%407M272.55%190M
-Less:Impairment of capital assets 1,041.67%548M-31.52%530M261.17%679M-55.95%1.08B-95.29%68M71.43%48M-4.44%774M13.94%188M319.01%2.45B689.62%1.45B
-Less:Other special charges 43.31%450M-82.03%83M-54.51%106M-49.83%1.04B38.10%29M61.03%314M-36.63%462M-79.27%233M196.42%2.07B-96.41%21M
-Gain on sale of business -------------93.48%3M-----------------9.80%46M----
-Gain on sale of property,plant,equipment ------------38.89%25M----------------157.14%18M----
Other non- operating income (expenses) 185.71%20M-95.83%1M300.00%18M46.15%-14M-820.00%-36M800.00%7M400.00%24M57.14%-9M-36.84%-26M-61.54%5M
Income before tax -606.25%-324M73.35%-246M-71.69%-467M80.27%-624M142.29%507M-61.45%64M20.43%-923M71.99%-272M-580.70%-3.16B-585.14%-1.2B
Income tax 675.00%69M4,037.50%630M-173.68%-52M98.91%-7M-72.48%41M-111.21%-12M98.22%-16M-1,050.00%-19M-404.74%-643M720.83%149M
Earnings from equity interest net of tax --3M100.00%2M---4M-90.48%2M0.00%1M------1M----133.33%21M--1M
Net income -606.49%-390M3.53%-874M-65.61%-419M75.39%-615M134.67%467M32.76%77M-249.81%-906M73.42%-253M-648.03%-2.5B-786.18%-1.35B
Net income continuous Operations -613.16%-390M3.53%-874M-65.61%-419M75.39%-615M134.67%467M31.03%76M-248.46%-906M73.42%-253M-648.03%-2.5B-792.05%-1.35B
Minority interest income 487.50%47M17.14%-29M-748.48%-280M-5.66%-56M112.50%4M166.67%8M-29.63%-35M-1,200.00%-33M-235.90%-53M-557.14%-32M
Net income attributable to the parent company -733.33%-437M2.98%-846M36.82%-139M77.15%-559M135.24%463M23.21%69M-275.86%-872M76.96%-220M-686.57%-2.45B-726.42%-1.31B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -733.33%-437M2.98%-846M36.82%-139M77.15%-559M135.24%463M23.21%69M-275.86%-872M76.96%-220M-686.57%-2.45B-726.42%-1.31B
Basic earnings per share -750.00%-0.393.85%-0.7540.00%-0.1277.27%-0.5137.27%0.4120.00%0.06-271.43%-0.7876.74%-0.2-678.95%-2.2-685.71%-1.1
Diluted earnings per share -750.00%-0.393.85%-0.7540.00%-0.1277.27%-0.5137.27%0.4120.00%0.06-271.43%-0.7876.74%-0.2-678.95%-2.2-685.71%-1.1
Dividend per share 0000000000
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Infectious Disease
Infectious Disease
Intraday+0.95%